
The Regional Medical Advisor Pipeline (RMAP) is a vital part of Global DR&S, serving as a field-based scientific resource responsible for the external scientific engagement (ESE) strategy for designated programs within a Therapeutic Area (TA) in their region.
Collaborating closely with internal and external stakeholders, the RMAP will work on designated trials and cross-program scientific engagement needs. The RMAP will establish and maintain relationships with Key External Experts (KEEs) within a specific region to advise on Alexion’s clinical development strategy and trial execution within a TA.
Reporting directly to the Global TA Head of External Scientific Engagement for Hematology, Nephrology & Transplants (HNT), the RMAP will play a crucial role in ensuring the successful performance of clinical trials, supporting activities such as early insight collection, guiding feasibility, and enhancing trial recruitment and retention.
30-Sep-2026
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy